Amneal Pharmaceuticals, Inc.

Q4 2021 13F Holders

Symbol
AMRX
CUSIP
03168L105
Type
Equity
Class
COM STK CL A
Num filings
165
Total reported value, excl. options
$482 M
Manager Report Date Value ($000) Shares Option Type